KRMD Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of -7.48% compared to KORU Medical Systems, Inc.'s net margin of --. KORU Medical Systems, Inc.'s return on equity of -22.13% beat Picard Medical's return on equity of --.

KORU Medical Systems, Inc. has a consensus price target of $6.25, signalling upside risk potential of 0.32%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that KORU Medical Systems, Inc. has higher upside potential than Picard Medical, analysts believe KORU Medical Systems, Inc. is more attractive than Picard Medical.

KORU Medical Systems, Inc. has a beta of 0.576, which suggesting that the stock is 42.435% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

KORU Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

KORU Medical Systems, Inc. quarterly revenues are $10.4M, which are larger than Picard Medical quarterly revenues of --. KORU Medical Systems, Inc.'s net income of -$778K is higher than Picard Medical's net income of --. Notably, KORU Medical Systems, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems, Inc. is 7.35x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -7.48% compared to KORU Medical Systems, Inc.'s net margin of -862.39%. KORU Medical Systems, Inc.'s return on equity of -22.13% beat VolitionRX Ltd.'s return on equity of --.

KORU Medical Systems, Inc. has a consensus price target of $6.25, signalling upside risk potential of 0.32%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 780%. Given that VolitionRX Ltd. has higher upside potential than KORU Medical Systems, Inc., analysts believe VolitionRX Ltd. is more attractive than KORU Medical Systems, Inc..

KORU Medical Systems, Inc. has a beta of 0.576, which suggesting that the stock is 42.435% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

KORU Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

KORU Medical Systems, Inc. quarterly revenues are $10.4M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. KORU Medical Systems, Inc.'s net income of -$778K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, KORU Medical Systems, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems, Inc. is 7.35x versus 17.13x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -7.48% compared to KORU Medical Systems, Inc.'s net margin of -1037.17%. KORU Medical Systems, Inc.'s return on equity of -22.13% beat Catheter Precision, Inc.'s return on equity of -192.05%.

KORU Medical Systems, Inc. has a consensus price target of $6.25, signalling upside risk potential of 0.32%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2161.97%. Given that Catheter Precision, Inc. has higher upside potential than KORU Medical Systems, Inc., analysts believe Catheter Precision, Inc. is more attractive than KORU Medical Systems, Inc..

KORU Medical Systems, Inc. has a beta of 0.576, which suggesting that the stock is 42.435% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

KORU Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

KORU Medical Systems, Inc. quarterly revenues are $10.4M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. KORU Medical Systems, Inc.'s net income of -$778K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, KORU Medical Systems, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems, Inc. is 7.35x versus 7.90x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -7.48% compared to KORU Medical Systems, Inc.'s net margin of 3.93%. KORU Medical Systems, Inc.'s return on equity of -22.13% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

KORU Medical Systems, Inc. has a consensus price target of $6.25, signalling upside risk potential of 0.32%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 93.3%. Given that Xtant Medical Holdings, Inc. has higher upside potential than KORU Medical Systems, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than KORU Medical Systems, Inc..

KORU Medical Systems, Inc. has a beta of 0.576, which suggesting that the stock is 42.435% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

KORU Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

KORU Medical Systems, Inc. quarterly revenues are $10.4M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. KORU Medical Systems, Inc.'s net income of -$778K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, KORU Medical Systems, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems, Inc. is 7.35x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.